SCHEMBL6360706

SCHEMBL6360706

O=C(Nc1ccc(Br)cc1C(=O)O)c1cc(S(=O)(=O)Nc2ccc(F)c(Cl)c2)c(F)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPA1 P27694 2/20 0.50
METAP2 P50579 1/20 0.47
SLC10A2 Q12908 1/20 0.46
SLC10A1 Q14973 1/20 0.46
SLC10A6 Q3KNW5 1/20 0.46
MIF P14174 1/20 0.46
MAPT P10636 1/20 0.46
ACLY P53396 1/20 0.45
FABP4 P15090 1/20 0.45
FABP5 Q01469 1/20 0.45
GPR27 Q9NS67 2/20 0.45
WDR5 P61964 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6352408 0.87 NPC1 (0.55) RPA1MIFMAPTMEN1KMT2A
SCHEMBL6347755 0.84 MIF (0.54) RPA1METAP2SLC10A2SLC10A1SLC10A6
SCHEMBL6833646 0.83 RPA1 (0.51) RPA1METAP2SLC10A2SLC10A1SLC10A6
SCHEMBL6818512 0.83 RPA1 (0.51) RPA1METAP2SLC10A2SLC10A1SLC10A6
SCHEMBL6351997 0.73 CPT2 (0.48) MAPTMEN1KMT2ATP53
SCHEMBL6353713 0.72 MAPT (0.55) MAPTMEN1KMT2ATP53
SCHEMBL6346651 0.72 METAP2 (0.65) METAP2SLC10A2SLC10A1SLC10A6MIF
SCHEMBL1307332 0.72 PPARG (0.71) METAP2ACLYMEN1KMT2AAKR1C2
SCHEMBL7209357 0.72 SLC10A6 (0.76) METAP2SLC10A2SLC10A1SLC10A6MAPT
SCHEMBL6352359 0.72 METAP2 (0.71) RPA1METAP2SLC10A2SLC10A1SLC10A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 RPA1 3847/4885METAP2 1269/4885SLC10A2 2503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.